Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine

Neurosci Lett. 1994 Apr 25;171(1-2):183-6. doi: 10.1016/0304-3940(94)90635-1.

Abstract

The effect of prolonged uptake inhibition with fluoxetine (10 mg/kg/day i.p. x 14 days) on extracellular serotonin (5-HT) in the rat diencephalon was monitored using in vivo microdialysis. The increase in extracellular 5-HT after repeated administration of fluoxetine was significantly greater than the increase produced by a single injection of this uptake blocker. This difference may have been due to a decrease in somatodendritic autoreceptor sensitivity, since the response to a low dose of the 5-HT1A agonist 8-OH-DPAT (25 micrograms/kg i.v.) was abolished in the chronic rats, while the response to a high dose (100 micrograms/kg i.v.) was attenuated as compared to animals injected once with fluoxetine.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • 8-Hydroxy-2-(di-n-propylamino)tetralin / pharmacology
  • Animals
  • Diencephalon / drug effects
  • Diencephalon / metabolism
  • Electrophysiology
  • Extracellular Space / drug effects
  • Extracellular Space / metabolism
  • Fluoxetine / pharmacology*
  • Male
  • Microdialysis
  • Rats
  • Rats, Sprague-Dawley
  • Selective Serotonin Reuptake Inhibitors / pharmacology*
  • Serotonin / metabolism*

Substances

  • Serotonin Uptake Inhibitors
  • Fluoxetine
  • Serotonin
  • 8-Hydroxy-2-(di-n-propylamino)tetralin